Phil Overview
- Founded
- 2015
- Status
- Private
- Employees
- 98
- Latest Deal Type
- Series B
- Latest Deal Amount
- $25M
- Investors
- 15
Phil General Information
Description
Operator of an end-to-end healthcare platform created to make specialty drugs more available and affordable to consumers. The company's platform connects patients, prescribers, pharmacies and manufacturers and provides an end-to-end prescription management service as a convenient alternative to traditional pharmaceutical management, thus enabling patients to get access to low-cost medicines and better outcomes to rare diseases.
Contact Information
Website
Formerly Known As
REX Technology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Information Services (B2C)
Media and Information Services (B2B)
Other Healthcare Technology Systems
Primary Office
- 234 Front Street
- 4th Floor
- San Francisco, CA 94111
- United States
+1 (855) 000-0000
Phil Timeline
Phil Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 15-May-2019 | $25M | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Early Stage VC (Series A) | 16-Aug-2017 | 0000 | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC | 29-Nov-2016 | $7.5M | $9.6M | 000.00 | Completed | Generating Revenue |
| 1. Seed Round | 01-Aug-2015 | $2.11M | $2.11M | Completed | Startup |
Phil Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed | 4,125,112 | $0.000010 | 8% | $0.51 | $0.51 | 1x | $0.51 | 8.59% |
Phil Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an end-to-end healthcare platform created to make specialty drugs more available and affordable to consumers
Other Healthcare Services
San Francisco, CA
98
As of 2020
000.00
00.00
0000-00-00
00000000000
000.00
00000000
em ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
00000 0000000000 00000000
San Diego, CA
0000
As of 0000
00000
0000
00000
000000
a. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000000000 0000000 (0000000000)
Boston, MA
00
As of 0000
000.00
000000&0
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialPhil Competitors (13)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MedImpact HealthCare Systems | Formerly PE-Backed | San Diego, CA | 0000 | 00000 | 0000 | 00000 |
| 000000 | Formerly VC-backed | Boston, MA | 00 | 000.00 | 000000&0 | 000.00 |
| 000000000 | Corporation | Mission, KS | ||||
| 000000 000000 | Formerly VC-backed | Plano, TX | 00 | 000.00 | 000000&0 | 000.00 |
| 0000000 | Formerly VC-backed | Jersey City, NJ | 00 | 000.00 | 000000&0 | 000.00 |
Phil Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Deepak Thomas | Founder, Chief Executive Officer & Board Member | ||
| Will Goldfarb JD | Head, Business Operations | ||
| Fang-Yu Lin | Head of Products & Design |
Phil Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Deepak Thomas | Phil | Founder, Chief Executive Officer & Board Member | 000 0000 |
| Omar El-Ayat | Crosslink Capital | Board Member | 000 0000 |
Phil Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPhil Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Avtar Investments | Family Office | Minority | 000 0000 | 000000 0 | |
| GreatPoint Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Proton Enterprises | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Tarsadia Investments | Family Office | Minority | 000 0000 | 000000 0 | |
| Hedgewood | Venture Capital | Minority | 000 0000 | 000000 0 |